Hologic Inc (HOLX)
Liquidity ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 3.89 | 3.47 | 4.42 | 4.41 | 4.21 | 4.12 | 3.91 | 2.97 | 2.74 | 2.39 | 1.65 | 2.57 | 2.46 | 1.79 | 1.47 | 1.31 | 1.57 | 1.68 | 1.57 | 1.45 |
| Quick ratio | 2.92 | 2.77 | 3.54 | 2.73 | 3.32 | 3.21 | 3.11 | 2.41 | 1.94 | 1.59 | 1.21 | 1.96 | 1.97 | 1.40 | 1.09 | 0.94 | 0.92 | 1.17 | 1.00 | 0.92 |
| Cash ratio | 2.17 | 2.26 | 2.84 | 2.73 | 2.59 | 2.53 | 2.39 | 1.76 | 1.11 | 0.88 | 0.57 | 0.79 | 0.82 | 0.57 | 0.55 | 0.54 | 0.37 | 0.56 | 0.42 | 0.38 |
Hologic Inc's liquidity ratios show a generally positive trend over the periods analyzed. The current ratio, which measures the company's ability to cover its short-term liabilities with its current assets, has consistently improved, indicating a strong liquidity position. It increased from 1.45 in December 2019 to 3.89 in December 2023.
Similarly, the quick ratio, which provides a more conservative measure of liquidity by excluding inventory from current assets, also shows a positive trend. It increased from 0.92 in March 2019 to 2.92 in December 2023, reflecting the company's ability to meet its short-term obligations without relying on inventory.
The cash ratio, which measures the company's ability to cover its current liabilities with its cash and cash equivalents, has also shown improvement. It increased from 0.38 in March 2019 to 2.17 in December 2023, indicating a stronger cash position.
Overall, Hologic Inc's liquidity ratios suggest that the company has a solid financial position and is well-equipped to meet its short-term obligations. The improving trend in these ratios indicates efficient management of working capital and a strong cash position, which are positive indicators for investors and creditors alike.
Additional liquidity measure
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash conversion cycle | days | 145.96 | 139.09 | 155.46 | 102.09 | 151.32 | 131.26 | 120.01 | 114.53 | 131.22 | 117.80 | 121.76 | 134.24 | 153.00 | 150.41 | 140.35 | 119.66 | 105.03 | 113.26 | 121.30 | 113.91 |
The cash conversion cycle of Hologic Inc, a measure of how long it takes for the company to convert its investments in inventory and other resources into cash flows from sales, has fluctuated over the past few years.
The company's cash conversion cycle ranged from a low of 102.09 days in March 2023 to a high of 155.46 days in June 2023. This indicates that Hologic Inc took a shorter time to convert its investments into cash in March 2023 while facing a longer cash conversion cycle in June 2023.
Overall, Hologic Inc's cash conversion cycle has shown some variability, with periods of improvement and deterioration. It is important for the company to closely monitor and manage its inventory levels, accounts receivable, and accounts payable in order to optimize its cash conversion cycle and enhance its working capital efficiency.